Tonix Pharmaceuticals Holding (TNXP) Net Margin (2023 - 2025)
Historic Net Margin for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Q3 2025 value amounting to 972.95%.
- Tonix Pharmaceuticals Holding's Net Margin fell 4693000.0% to 972.95% in Q3 2025 from the same period last year, while for Sep 2025 it was 963.38%, marking a year-over-year increase of 2344700.0%. This contributed to the annual value of 1288.25% for FY2024, which is 2135300.0% up from last year.
- Tonix Pharmaceuticals Holding's Net Margin amounted to 972.95% in Q3 2025, which was down 4693000.0% from 1415.02% recorded in Q2 2025.
- In the past 5 years, Tonix Pharmaceuticals Holding's Net Margin ranged from a high of 503.65% in Q3 2024 and a low of 3567.75% during Q2 2024
- Moreover, its 3-year median value for Net Margin was 723.0% (2023), whereas its average is 1114.96%.
- Over the last 5 years, Tonix Pharmaceuticals Holding's Net Margin had its largest YoY gain of 21527400bps in 2025, and its largest YoY loss of -4693000bps in 2025.
- Quarter analysis of 3 years shows Tonix Pharmaceuticals Holding's Net Margin stood at 723.0% in 2023, then fell by -18bps to 856.24% in 2024, then dropped by -14bps to 972.95% in 2025.
- Its Net Margin stands at 972.95% for Q3 2025, versus 1415.02% for Q2 2025 and 692.84% for Q1 2025.